Member access

4-Traders Homepage  >  Shares  >  Nasdaq  >  Arena Pharmaceuticals, Inc.    ARNA   US0400471027

SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
 News SummaryMost relevantAll newsSector news 
Most relevant news about ARENA PHARMACEUTICALS, INC
03/07 ARENA PHARMACEUTICALS : Provides Corporate Update and Reports Fourth Quarter and..
03/04 ARENA PHARMACEUTICALS : Announces Fourth Quarter and Full Year 2014 Financial Re..
03/02 ARENA PHARMACEUTICALS : reports 4Q loss
03/02 ARENA PHARMACEUTICALS : Provides Corporate Update and Reports Fourth Quarter and..
02/23 ARENA PHARMACEUTICALS : to Present at the 2015 RBC Capital Markets Healthcare Co..
02/23 ARENA PHARMACEUTICALS : Announces Fourth Quarter and Full Year 2014 Financial Re..
02/18 ARENA PHARMACEUTICALS : to Present at the 2015 RBC Capital Markets Healthcare Co..
02/03 ARENA PHARMACEUTICALS : Announces Marketing Approval in South Korea of BELVIQ® (..
02/02 ARENA PHARMACEUTICALS : to Present at the 17th Annual BIO CEO & Investor Confere..
01/21 ARENA PHARMACEUTICALS : Announces Agreement to Sell Common Stock
01/20 ARENA PHARMACEUTICALS : Announces Public Offering of Common Stock
01/13 APPLE : Most active Nasdaq-traded stocks
01/12 ARENA PHARMACEUTICALS : Initiates Phase 2 Clinical Trial Evaluating Ralinepag fo..
01/09 ARENA PHARMACEUTICALS : Reports on Eisai's New Marketing Initiatives for BELVIQ®..
01/08 APPLE : Most active Nasdaq-traded stocks
More most relevant news
All news about ARENA PHARMACEUTICALS, INC
03/25 ARENA PHARMACEUTICALS : Patent Issued for Crystalline Forms of ®-8-Chloro-1-Meth..
03/07 ARENA PHARMACEUTICALS : Provides Corporate Update and Reports Fourth Quarter and..
03/04 ARENA PHARMACEUTICALS : Announces Fourth Quarter and Full Year 2014 Financial Re..
03/02 ARENA PHARMACEUTICALS : reports 4Q loss
03/02 ARENA PHARMACEUTICALS : Provides Corporate Update and Reports Fourth Quarter and..
02/23 ARENA PHARMACEUTICALS : to Present at the 2015 RBC Capital Markets Healthcare Co..
02/23 ARENA PHARMACEUTICALS : Announces Fourth Quarter and Full Year 2014 Financial Re..
02/19 ARENA PHARMACEUTICALS : Patent Issued for Processes for the Preparation of 5-HT...
02/18 ARENA PHARMACEUTICALS : to Present at the 2015 RBC Capital Markets Healthcare Co..
02/11 ARENA PHARMACEUTICALS : Announces Marketing Approval in South Korea of BELVIQ® l..
More news
Sector news : Biotechnology & Medical Research - NEC
06:25a Intercept Pharmaceuticals Announces Proposed Offering of Common Stock
06:07a QUINTILES TRANSNATIONAL : Forbes Names Quintiles One of America’s Best Emp..
03/30 PUMA BIOTECHNOLOGY : NYSE stocks posting largest percentage increases
03/27 ISIS PHARMACEUTICALS : Earnings Coverage - Isis Pharma
03/26 Alliance invokes Elliott track record in appeal against board shake-up
03/26 ACTELION : receives marketing approval for Opsumit (macitentan) in pulmonary art..
More sector news : Biotechnology & Medical Research - NEC
News from SeekingAlpha
03/30 Arena - Assessing Belviq In South Korea
03/30 Orexigen Will Make The Obesity Space A Two-Product Race
03/28 ARENA : Belviq Sales Flatter Than Needed - Q1 Revenue Miss Likely
03/27 Arena Investors Need To Pay Attention To Competition
03/24 After Hours Gainers / Losers
03/23 OREXIGEN : Contrave Gathering Momentum


Advertisement
Chart
Duration : Period :
Arena Pharmaceuticals, Inc Technical Analysis Chart | ARNA | US0400471027 | 4-Traders
Income Statement Evolution
More Financials
Dynamic quotes  
ON
| OFF